Explore

Future Of Health is seeking stronger ways to close one of the most persistent gaps in competitive sport: the difference between what athletes can do in training and what they consistently deliver when it matters most. Many athletes perform at a high level in controlled practice settings, yet see execution decline in competition when faced with noise, crowds, judging, visibility, expectation, and the consequences of a single moment. This challenge affects athletes across performance levels, as well as the coaches, psychologists, and support teams responsible for preparing them. In high-stakes environments, technical ability alone is often not enough. Competition-day performance depends on whether athletes can regulate attention, emotion, and decision-making under pressure while staying connected to the routines and skills they have trained. The issue is becoming more important as sport is increasingly shaped by digital exposure, public scrutiny, and intensified performance demands. Organizations need more practical and measurable ways to prepare athletes for realistic competitive conditions, not just ideal training environments. That includes understanding how pressure affects execution, confidence, recovery after mistakes, and repeatability over time. This challenge focuses on the need for an applied framework that links mental preparation directly to on-field or on-court performance. It is especially relevant in settings with access to facilities, coaching, and multidisciplinary expertise that can integrate sport psychology into everyday training and competition readiness in a scalable, evidence-informed way.

In professional sports, a decline in performance, the onset of illness, or a developing injury is often identified only after clear symptoms appear: pain, reduced functional capacity, fatigue, or absence from training and competition. By the time these warning signs become visible, the athlete may already be facing lost training time, impaired recovery, lower performance, and increased medical and financial burden for the team and support system. This challenge is focused on athletes for whom sport is their primary occupation, including elite, professional, and high-performance players who operate under continuous physical and mental demands. These individuals are expected to maintain peak readiness while coping with intense training loads, travel, competition stress, and limited recovery windows. In such environments, even small undetected changes in physiology, biomechanics, sleep, workload tolerance, or mental state can quickly develop into meaningful setbacks. The opportunity is to move from reactive care to early identification and proactive intervention. We are seeking approaches that can help detect subtle signals of decline, illness risk, or injury risk before they become clinically or functionally significant. Solutions may draw on data, monitoring tools, predictive models, integrated assessments, or new methods for translating complex information into practical decisions for athletes, coaches, and medical teams. This is important not only for protecting athlete health and career longevity, but also for improving consistency, resilience, and performance outcomes. A successful solution should support earlier action, reduce avoidable downtime, and enable a more precise, personalized, and preventive model of care in high-performance sport.פתרונות מישראל בלבד

A digital, data-driven public needs programming solution for local authorities that optimizes municipal assets used by residents over many years. The solution helps cities and municipalities plan, allocate, and adapt public facilities based on demographic trends, long-term demand, and evolving community needs. Its unique value lies in combining progressive planning, digital delivery, long-range simulation, and a dedicated proprietary modeling tool for smarter municipal decision-making.

ViVac’s product is a pre-clinical synthetic RNA-LNP platform for cancer immunotherapy designed for solid tumors such as liver and ovarian cancer. The platform safely mimics viral infection by delivering a full viral blueprint, including immunostimulators, into tumors using lipid nanoparticles rather than live virus. Its core promise is to combine the potency of oncolytic viral approaches with RNA-level safety: the RNA-LNP acts as a pro-drug, enables local single-cycle viral replication, and uses the poliovirus receptor CD155, which is overexpressed in many tumors, for tumor-specific targeting. The solution is intended to train the immune system against both viral and tumor antigens, activating intracellular and extracellular immune pathways to stimulate T-cells as well as B-cells and antibodies. This dual immune activation is positioned as a major differentiator versus checkpoint inhibitors, oncolytic viruses, and mRNA vaccines, which the company describes as limited by efficacy, safety, manufacturing complexity, or weak and short-lived responses. ViVac’s unique selling proposition is that it is the only platform presented here to combine intra- and extracellular immune activation with the scalability and safety profile of an RNA-LNP system, while aiming to generate amplified responses against both local and distant tumors.